KYUN: Disease-causing variants individuals ke beech alag hoti hain. Unke specific mutations identify karne ke liye aapko patient ka actual genetic code chahiye.
KYA: Molecular biomarkers use karke disease progression aur treatment response track karo.
KAISE:
Circulating tumor DNA (ctDNA): Cancer DNA blood mein shed karta hai; resistance mutations detect karne ke liye use sequence karo
Minimal residual disease (MRD): Treatment ke baad cancer cells ki ultra-sensitive detection
KYUN: Precision medicine dynamic hai. Cancers evolve hote hain; drugs kaam karna band kar deti hain. Monitoring guide karti hai ki therapies kab switch karni hain.
Turnaround time: NGS mein 2-4 weeks lagte hain (cancer patients ke paas itna time nahi ho sakta)
Data interpretation: AI help karta hai, lekin bahut saare variants abhi bhi unclassified hain
Equity: Genomic databases European ancestry ki taraf biased hain → African, Asian populations ke liye worse predictions
Recall 12-Saal Ke Bache Ko Explain Karo
Sochiye aapka body ek LEGO set jaisa hai. Sabko same basic instruction manual milta hai (human genome), lekin kuch logon ke manual mein typos hoti hain—shayad ek piece ki shape thodi alag ho.
Old medicine aise thi jaise sab kuch toot jaane par sabko same replacement piece dena. Lekin agar aapki typo ne aapke piece ko alag shape ka bana diya, toh standard replacement fit nahi hoga!
Kuch bacche milk process nahi kar sakte (lactose intolerance) ek gene typo ki wajah se → hum unhe milk peene par force nahi karte
Kuch log medicine bahut slowly tod dete hain → unhe lower dose chahiye warna bimaar pad jaate hain
Yeh aisa hai jaise video game ki custom difficulty ho: game aapke skill level ke hisaab se adjust hoti hai, sab ke saath same treat karne ki bajaye.
Precision medicine kya hai? :: Ek approach jo treatment aur prevention ke liye genes, environment, aur lifestyle mein individual variability ko account mein leti hai, har patient ke liye therapies tailor karne ke liye genomic data use karti hai.
Precision medicine mein genomic sequencing ke do main types kya hain?
(1) Germline sequencing (blood/saliva se inherited DNA) aur (2) Somatic sequencing (biopsy se tumor-specific mutations).
BRCA1 mutation carriers mein breast cancer risk zyada kyun hoti hai?
BRCA1 ek DNA repair gene hai. Loss-of-function mutations homologous recombination repair ko impair karte hain, jisse mutations accumulate hoti hain aur cancer hota hai (55-72% lifetime risk vs 12% general population).
Pharmacogenomics kya hai?
Yeh study hai ki genes kisi insaan ka drugs ke response ko kaise affect karte hain, metabolizing enzymes mein variants ke basis par efficacy aur side effects predict karna (jaise, warfarin ke liye CYP2C9).
CYP2C9 *3 carriers ko lower warfarin doses kyun chahiye? :: CYP2C9 *3 ek slow-metabolizer allele hai. Warfarin zyada slowly clear hoti hai, jisse accumulation hoti hai aur normal dose par bleeding risk badh jaati hai.
ctDNA kya hai aur cancer monitoring mein kyun useful hai?
Circulating tumor DNA—cancer DNA ke fragments jo bloodstream mein shed hote hain. ctDNA sequence karke naye resistance mutations imaging se pehle detect hote hain, jo therapy switches guide karta hai.
Lung cancer mein osimertinib kis mutation ko target karta hai?
EGFR exon 19 deletion ya L858R mutation. Osimertinib ek EGFR tyrosine kinase inhibitor hai jo overactive mutant EGFR protein ko block karta hai jo tumor growth drive karta hai.
Pathogenic aur VUS variants mein kya fark hai?
Pathogenic variants confirmed disease-causing hote hain; VUS (variant of uncertain significance) ka impact unclear hota hai—benign, pathogenic, ya neutral ho sakta hai. VUS ko clinical action se pehle aur evidence chahiye.
Polygenic diseases ke liye precision medicine kam effective kyun hai?
Polygenic diseases (diabetes, heart disease) bahut saare variants se result karti hain jin mein se har ek ka small individual effect hota hai + environment. Monogenic diseases ki tarah ek strong mutation nahi hoti, isliye single therapies se predict ya target karna mushkil hota hai.
Precision medicine mein ek common ethical concern kya hai?
Genetic discrimination—insurance ya employers genomic data use karke coverage/employment deny karte hain; saath hi incidental findings (test ke purpose se unrelated disease risks pata chalna, jaise cancer test karte waqt Alzheimer's risk jaanna).